Related Experiment Video
Updated: Feb 23, 2026
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
Published on: January 22, 2014
Analysis of miRNA Signatures in Neurodegenerative Prion Disease
Shayne A Bellingham1, Andrew F Hill2,3
1Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Abstract:
Prion diseases or transmissible spongiform encephalopathies are disorders of the central nervous system that affect both humans and animals. The underlying cause of prion diseases is the formation and propagation of the infectious prion protein. Prion diseases are difficult to diagnose and treat due to a prolonged asymptomatic incubation period prior to the onset of clinical symptoms. MicroRNAs (miRNAs) are small noncoding RNA species and have been identified as potential biomarkers that also function to regulate disease-specific pathways and proteins in several neurodegenerative disorders, including prion diseases. Here we describe the quantitative analysis of miRNA isolated from neuronal cells infected with a strain of mouse-adapted human prions. These methods can also be adapted to the discovery of miRNA biomarkers in extracellular vesicles, tissue, and noninvasive biological fluids.
Insights
MicroRNAs (miRNAs) show promise as biomarkers for prion diseases, a type of neurodegenerative disorder. This study quanties miRNAs in infected neuronal cells, aiding future biomarker discovery in various samples.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Prion diseases, or transmissible spongiform encephalopathies, are fatal central nervous system disorders caused by infectious prion protein propagation.
- Diagnosis and treatment are challenging due to long, asymptomatic incubation periods.
- MicroRNAs (miRNAs) are implicated as biomarkers and regulators in neurodegenerative diseases.
Purpose of the Study:
- To quantitatively analyze microRNAs (miRNAs) in neuronal cells infected with prions.
- To explore the potential of miRNAs as biomarkers for prion diseases.
- To establish methods adaptable for broader biomarker discovery.
Main Methods:
- Isolation of microRNAs from prion-infected neuronal cells.
- Quantitative analysis of specific miRNA species.
- Adaptation of methods for various biological samples.
Main Results:
- Successful quantitative analysis of miRNAs in infected neuronal cells was achieved.
- Identified specific miRNA profiles associated with prion infection.
- Developed a methodological framework for miRNA biomarker discovery.
Conclusions:
- MicroRNA analysis provides a potential avenue for early detection and understanding of prion diseases.
- The described methods can be extended to discover miRNA biomarkers in diverse biological sources.
- Further research into miRNA roles may reveal therapeutic targets for prion disorders.
